glp 1 drugs tirzepatide Comparing Ozempic, Wegovy and Other GLP-1 People Can Lose Their Zest
Description
DOI: 10.3390/nu15224809
After weighting the cohorts for inverse probability of treatment, the researchers found that, compared with second-line GLDs, ADRD risk was significantly lower with both GLP-1 receptor agonists (adjusted HR = 0.67
A revolution in obesity treatment
Mechanisms controlling glucose-induced GLP-1 secretion in human small intestine
